Hypertension remains a vital, modifiable risk factor in the prevention of cardiovascular disease. However, many patients do not achieve their therapeutic goals for numerous reasons which can include poor disease insight and nonadherence. Pharmacists can be key players in controlling hypertension, given their medication knowledge and patient counseling skills, yet they remain an underutilized resource in the management of chronic disease states. Various models exist that allow pharmacists to provide direct patient-centered care but practices differ from state to state since pharmacists are not recognized nationally as healthcare providers. This article aims to provide an update on the proven methods in which pharmacists contribute to the management of hypertensive patients.
Several recently published studies demonstrate the positive impact of pharmacist intervention and care on patient outcomes in ambulatory and community settings. These practice models include medication therapy management, collaborative drug therapy management, telehealth and team-based care.
The role of the pharmacist in hypertension encompasses medication management, disease state education and patient counseling and is most successful when integrated into the patient's care team. Further validation through larger, prospective trials and evaluation of long-term outcomes, such as mortality, remain viable research opportunities.
aMontefiore Medical Center, Department of Cardiology, Bronx
bArnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, New York, New York, USA
Correspondence to Katherine E. Di Palo, PharmD, BCACP, BCGP, Montefiore Medical Center, Jack D. Weiler Campus, 1825 Eastchester Road, Bronx NY 10461, USA. Tel: +1 917 828 7063; e-mail: email@example.com